Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-032447

Chief Executive Officer sold 8,800 shares at an average $51.74 ($455,313)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-05-21 Sale −1,500 $51.67 $77,505 178,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-05-21 Sale −2,000 $52.83 $105,660 176,578 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-05-21 Sale −900 $53.64 $48,276 175,678 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-05-22 Sale −4,400 $50.88 $223,872 171,278 I: show line 4 in the form
Open-market sales · 8,800 sh · avg $51.74 · $455,313
Loading xslF345X03/doc4.xml…